Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Autor: Lucas López-Valero, Rosa Macías-Ruiz, Adela Briones-Través, Francisco Bermúdez-Jiménez, Juan Jiménez-Jáimez, Jose Miguel Sequí-Sabater, Ricardo Rubini-Costa, Francisco Sanz-Herrera, Hadi Nagib-Raya, María Rivadeneira-Ruiz, Elena Sola-García, Juan Luis Romero-Cabrera, Ricardo Rivera-López, María Molina-Jiménez, Eduardo Moreno-Escobar, Luis Tercedor, Miguel Álvarez López, Felipe Fernández-Vázquez, Jose Antonio Aparicio-Gómez, Miguel Ángel López-Zúñiga, Carlos Gómez-Navarro, Javier Maíllo-Seco

Publikováno v: MEDICINA CLINICA
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Medicina Clinica

Supplementary data associated with this article can befound, in the online version, at https://doi.org/10.1016/j.medcli.2021.06.015
Introduction and purpose: Atrial fibrillation (AF) is common in patients admitted with severe COVID- 19. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b4403352b2489c9fb7dc1ef4fe63ff
https://hdl.handle.net/10481/81590